Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 209

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cohort Profile: The French E3N Cohort Study

Clavel-Chapelon, Françoise, for the E3N Study Group · 2015 · International Journal of Epidemiology

Abstract

The E3N (Etude Epidémiologique auprès de femmes de la Mutuelle Générale de l'Education Nationale) cohort was initiated in 1990 to investigate therisk factors associated with cancer and other major non-communicable diseases in women. The participants were insured through a national health system that primarily covered teachers, and were enrolled from 1990 after returning baseline self-administered questionnaires and providing informed consent. The cohort comprised nearly 100,000 women with baseline ages ranging from 40 to 65 years. Follow-up questionnaires were sent approximately every 2-3 years after the baseline and addressed general and lifestyle characteristics together with medical events (cancer, cardiovascular diseases, diabetes, depression, fractures and asthma, among others). The follow-up questionnaire response rate remained stable at approximately 80%. A biological material bank was generated and included blood samples collected from 25,000 women and saliva samples from an additional 47,000 women. Ageing among the E3N cohort provided the opportunity to investigate factors related to age-related diseases and conditions as well as disease survival. The new E4N complementary cohort (Epidemiology 4 kNowledge), which comprises the children and grandchildren of the E3N cohort as well as the children's fathers, will allow researchers to investigate key life periods during which exposures to environmental factors most strongly influence the later disease risk. The E3N and E4N cohort data will be used to investigate diseases and risk factors through a transgenerational approach. Requests for collaborations are welcome, particularly those in conjunction with rare diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyu184

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 32

  1. 10.1016/S0378-5122(98)00020-6 · DOI
  2. 10.1016/S0002-8223(02)90381-0 · DOI · Paper page
  3. 10.1002/ijc.20710 · DOI · Paper page
  4. Fournier A Fabre A Mesrine S Boutron-Ruault MC Berrino F Clavel-Chapelon F . Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol 2008 10;26:1260–68. · DOI · Paper page
  5. 10.1200/JCO.2008.21.6432 · DOI
  6. 10.1056/NEJMc090490 · DOI
  7. 10.1007/s10549-014-2934-6 · DOI
  8. Fournier A Dossus L Mesrine S Vilier A Boutron-Ruault MC Clavel-Chapelon F Chabbert-Buffet N . Risks of endometrial cancer associated with different menopausal hormone therapies in the E3N cohort, 1992-2008. Am J Epidemiol 2014, 9 July. Epub ahead of print. pii: kwu146. · DOI
  9. 10.1002/ijc.25504 · DOI
  10. 10.1007/s10654-012-9694-6 · DOI
  11. 10.1093/aje/kwr044 · DOI
  12. 10.1136/thx.2009.116079 · DOI
  13. 10.1503/cmaj.121490 · DOI
  14. 10.1161/ATVBAHA.109.196022 · DOI · Paper page
  15. 10.1038/sj.ijo.0803133 · DOI
  16. 10.1038/ijo.2011.66 · DOI
  17. 10.1158/1055-9965.EPI-12-0130 · doi:10.1158/1055-9965.epi-12-0130
  18. 10.1097/CEJ.0b013e328355ec04 · DOI
  19. 10.1093/ije/dyr097 · DOI
  20. 10.1093/aje/kwq258 · DOI
  21. Clavel-Chapelon F Guillas G Tondeur L Kernaleguen C Boutron-Ruault MC . Risk of differentiated thyroid cancer in relation to adult weight, height, and body shape over life: The French E3N cohort . Int J Cancer 2010;126:2984–90. · DOI
  22. 10.1677/ERC-10-0053 · DOI · Paper page
  23. 10.2337/dc09-1304 · DOI
  24. 10.1093/aje/kwp257 · DOI · Paper page
  25. 10.1158/1940-6207.CAPR-13-0325 · DOI
  26. 10.1097/MOL.0b013e3283404552 · DOI
  27. 10.1093/aje/kwn069 · DOI · Paper page
  28. 10.1158/1055-9965.EPI-10-0264 · DOI
  29. 10.1007/s00394-004-0523-x · DOI
  30. Howe GR Chiarelli AM Lindsay JP . Components and modifiers of the healthy worker effect: Evidence from three occupational cohorts and implications for industrial compensation. Am J Epidemiol 1988;128:1364–75. · DOI
  31. Savitz DA . Interpreting Epidemiologic Evidence: Strategies for Study Design and Analysis . New York: Oxford University Press, 2003. · DOI
  32. Kleinbaum DG Kupper LL Morgenstern H . Epidemiologic Research: Principles and Quantitative Methods . Hoboken, NJ:Wiley, 1982.

Cited by

See all 209

Metadata

Authors
Clavel-Chapelon, F., & for the E3N Study Group
Venue
International Journal of Epidemiology
Published
2014-09-10
Volume
44
Issue
3
Pages
801-809
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2148718224
Cited by
209
References
2
FWCI
4.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cohort Profile: The French E3N Cohort Study. https://app.cochat.ai/papers/10.1093/ije/dyu184
The paper
Clavel-Chapelon, F., & for the E3N Study Group. (2015). Cohort Profile: The French E3N Cohort Study. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyu184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.